World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
24320
World Ranking
17078
National Ranking
8558

Overview

Dan V. Iosifescu is affiliated with New York University in the United States and has a substantial body of research primarily focused on medicine and neuroscience. Their work spans multiple subfields including psychiatry and mental health, pharmacology, experimental and cognitive psychology, cognitive neuroscience, and radiology, nuclear medicine, and imaging.

The scientist's research covers several key topics such as treatment of major depression, laser applications in dentistry and medicine, tryptophan and brain disorders, anxiety, depression, psychometrics, treatment, cognitive processes, functional brain connectivity studies, mental health research topics, and obsessive-compulsive spectrum disorders.

Frequent coauthors collaborating with Dan V. Iosifescu include Katherine A. Collins, Sanjay J. Mathew, Ümit Tural, James W. Murrough, and Emily Stern. This network reflects a diverse and multidisciplinary team contributing to their line of research.

Publications by Dan V. Iosifescu appear most often in the following venues:

  • Biological Psychiatry
  • The Journal of Clinical Psychiatry
  • Journal of Affective Disorders
  • American Journal of Psychiatry
  • Photonics

Recent notable papers authored or coauthored by Dan V. Iosifescu include:

  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation, 2021, American Journal of Psychiatry
  • Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options, 2020, Frontiers in Psychiatry
  • A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia, 2020, Nature Medicine
  • Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial, 2021, World Psychiatry
  • Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial, 2022, American Journal of Psychiatry

Best Publications

  • Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Individuals With Major Depressive Disorder

    Diego A. Pizzagalli;A.M. Avram J. Holmes;Daniel G. Dillon;B.A. Elena L. Goetz

  • Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

    James W. Murrough;Dan V. Iosifescu;Lee C. Chang;Rayan K. Al Jurdi

  • A mega-analysis of genome-wide association studies for major depressive disorder

    Stephan Ripke;Naomi R Wray;Cathryn M Lewis;Steven P Hamilton

  • Reduced hedonic capacity in major depressive disorder: Evidence from a probabilistic reward task

    Diego A. Pizzagalli;Dan Iosifescu;Lindsay A. Hallett;Kyle G. Ratner

  • Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

    James W. Murrough;Andrew M. Perez;Sarah Pillemer;Jessica Stern

  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Roger S McIntyre;Roger S McIntyre;Joshua D Rosenblat;Joshua D Rosenblat;Charles B Nemeroff;Gerard Sanacora

  • Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder: A Randomized Clinical Trial

    Adriana Feder;Michael K. Parides;James W. Murrough;Andrew M. Perez

  • A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder

    Kyle A.B. Lapidus;Cara F. Levitch;Andrew M. Perez;Jess W. Brallier

  • Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

    Maurizio Fava;Marlene P. Freeman;Martina Flynn;Heidi Judge

  • Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.

    Amir Garakani;Amir Garakani;James W. Murrough;Rafael C. Freire;Robyn P. Thom

  • A digital brain atlas for surgical planning, model-driven segmentation, and teaching

    R. Kikinis;M.E. Shenton;D.V. Iosifescu;R.W. McCarley

  • Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies.

    James W. Murrough;Brian Iacoviello;Brian Iacoviello;Alexander Neumeister;Dennis S. Charney

  • Illness Progression, Recent Stress, and Morphometry of Hippocampal Subfields and Medial Prefrontal Cortex in Major Depression

    Michael T. Treadway;Michael L. Waskom;Daniel G. Dillon;Avram J. Holmes;Avram J. Holmes

  • Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.

    J. W. Murrough;L. Soleimani;K. E. DeWilde;K. A. Collins

  • QT interval and antidepressant use: a cross sectional study of electronic health records

    Victor M Castro;Caitlin C Clements;Shawn N Murphy;Vivian S Gainer

  • A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment

    Maurizio Fava;Lesley M. Graves;Franco Benazzi;Margaret J. Scalia

  • Ketamine Treatment and Global Brain Connectivity in Major Depression

    Chadi G Abdallah;Lynnette A Averill;Katherine A Collins;Paul Geha

  • Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.

    C. N. Haile;J. W. Murrough;D. V. Iosifescu;L. C. Chang

  • Ketamine safety and tolerability in clinical trials for treatment-resistant depression.

    Le-Ben Wan;Cara F. Levitch;Andrew M. Perez;Jess W. Brallier

  • A mega-analysis of genome-wide association studies for major depressive disorder

    S. Ripke;N. R. Wray;C. M. Lewis;S. P. Hamilton

Frequent Co-Authors

Maurizio Fava
Maurizio Fava Harvard University
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
James W. Murrough
James W. Murrough Icahn School of Medicine at Mount Sinai
Sanjay J. Mathew
Sanjay J. Mathew Baylor College of Medicine
Roy H. Perlis
Roy H. Perlis Harvard University
Dennis S. Charney
Dennis S. Charney Icahn School of Medicine at Mount Sinai
George I. Papakostas
George I. Papakostas Harvard University
Jonathan E. Alpert
Jonathan E. Alpert Harvard University
Diego A. Pizzagalli
Diego A. Pizzagalli Harvard University
Joseph R. Calabrese
Joseph R. Calabrese Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of healthcare careers. For those looking to enter nursing, understanding admission requirements is crucial. For example, some programs answer the question: do i need to take the teas test for lpn. This can help applicants find schools that don’t require standardized tests like TEAS, making the pathway more accessible.

Beyond nursing, there’s growing demand for leaders in healthcare management. Earning a degree in healthcare administration opens opportunities in hospitals, clinics, and public health organizations. These programs can often be completed online and are designed for those interested in overseeing healthcare systems.

Registered Nurses looking to become Family Nurse Practitioners can explore adn to fnp bridge programs. These accelerated online pathways offer a way to advance clinical skills and career prospects without repeating undergraduate coursework.

For individuals passionate about wellness, an online degree nutrition can lead to rewarding roles in dietetics or health education. No matter your interests, various online degrees can support healthcare career goals in the USA.

Best Scientists Citing Dan V. Iosifescu

Trending Scientists

Recently Published Articles